Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease
- 2 November 2004
- journal article
- review article
- Published by Elsevier in Molecular Brain Research
- Vol. 134 (1) , 67-75
- https://doi.org/10.1016/j.molbrainres.2004.09.011
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- 1‐Benzyl‐1,2,3,4‐tetrahydroisoquinoline, a Parkinsonism‐inducing endogenous toxin, increases α‐synuclein expression and causes nuclear damage in human dopaminergic cellsJournal of Neuroscience Research, 2004
- Metallothionein Attenuates 3-Morpholinosydnonimine (SIN-1)-Induced Oxidative Stress in Dopaminergic NeuronsAntioxidants and Redox Signaling, 2003
- Effect of Chronic Treatment with Riluzole on the Nigrostriatal Dopaminergic System in Weaver Mutant MiceExperimental Neurology, 2002
- Animal models of Parkinson's diseaseBioEssays, 2002
- ACUTE EXPOSURE TO ARSENITE INDUCES METALLOTHIONEIN ISOFORM-SPECIFIC GENE EXPRESSION IN HUMAN PROXIMAL TUBULE CELLSJournal of Toxicology and Environmental Health, Part A, 2001
- Dwarf mice and the ageing processNature, 1996
- Transgenic models of neurodegenerative diseasesCurrent Opinion in Neurobiology, 1996
- Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron diseaseNeuropathology and Applied Neurobiology, 1996
- A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiationNature Genetics, 1995
- Steps towards a mouse model of Alzheimer's diseaseBioEssays, 1995